Human medicines European public assessment report (EPAR): Aumseqa, Aumolertinib, Date of authorisation: 12/02/2026, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 27 February 2026 - 14:15

Human medicines European public assessment report (EPAR): Aumseqa, Aumolertinib, Date of authorisation: 12/02/2026, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/aumseqa

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters